Ibrutinib in primary central nervous system diffuse large B-cell lymphoma

The standard regimen for the treatment of newly diagnosed primary CNS lymphoma (PCNSL) remains regimens that contain high-dose methotrexate (MTX). While these regimens can provide control for some patients, there is a dearth of options for the treatment of patients with PCNSL who cannot tolerate MTX...

Descripción completa

Detalles Bibliográficos
Autores principales: T Low, Justin, B Peters, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163401/
https://www.ncbi.nlm.nih.gov/pubmed/32141313
http://dx.doi.org/10.2217/cns-2019-0022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163401/
https://www.ncbi.nlm.nih.gov/pubmed/32141313
http://dx.doi.org/10.2217/cns-2019-0022

Ejemplares similares